KR101409436B1 - 수불용성 폴리머 매트릭스를 포함하는 누점마개 - Google Patents

수불용성 폴리머 매트릭스를 포함하는 누점마개 Download PDF

Info

Publication number
KR101409436B1
KR101409436B1 KR1020097011060A KR20097011060A KR101409436B1 KR 101409436 B1 KR101409436 B1 KR 101409436B1 KR 1020097011060 A KR1020097011060 A KR 1020097011060A KR 20097011060 A KR20097011060 A KR 20097011060A KR 101409436 B1 KR101409436 B1 KR 101409436B1
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
polymer
passage
composition according
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020097011060A
Other languages
English (en)
Korean (ko)
Other versions
KR20090090320A (ko
Inventor
바흐람 애스가리안
매수드 에이. 초환
Original Assignee
알콘 리서치, 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알콘 리서치, 리미티드 filed Critical 알콘 리서치, 리미티드
Publication of KR20090090320A publication Critical patent/KR20090090320A/ko
Application granted granted Critical
Publication of KR101409436B1 publication Critical patent/KR101409436B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0042Materials resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/00772Apparatus for restoration of tear ducts

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020097011060A 2006-11-09 2007-11-08 수불용성 폴리머 매트릭스를 포함하는 누점마개 Expired - Fee Related KR101409436B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85783306P 2006-11-09 2006-11-09
US60/857,833 2006-11-09
PCT/US2007/084018 WO2008060929A1 (en) 2006-11-09 2007-11-08 Punctal plug comprising a water-insoluble polymeric matrix

Publications (2)

Publication Number Publication Date
KR20090090320A KR20090090320A (ko) 2009-08-25
KR101409436B1 true KR101409436B1 (ko) 2014-06-24

Family

ID=39284092

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097011060A Expired - Fee Related KR101409436B1 (ko) 2006-11-09 2007-11-08 수불용성 폴리머 매트릭스를 포함하는 누점마개

Country Status (14)

Country Link
US (1) US20080118932A1 (enExample)
EP (1) EP2086502B1 (enExample)
JP (1) JP5340161B2 (enExample)
KR (1) KR101409436B1 (enExample)
CN (1) CN101553207B (enExample)
AR (1) AR063620A1 (enExample)
AU (1) AU2007319437B2 (enExample)
BR (1) BRPI0718658A2 (enExample)
CA (1) CA2669642A1 (enExample)
ES (1) ES2415865T3 (enExample)
MX (1) MX2009004857A (enExample)
TW (1) TWI397426B (enExample)
WO (1) WO2008060929A1 (enExample)
ZA (1) ZA200902588B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105067698B (zh) 2009-11-05 2018-11-20 奎斯特诊断投资公司 用高分辨率质谱法量化胰岛素样生长因子-i和胰岛素样生长因子-ii
US8497079B2 (en) 2009-12-21 2013-07-30 Quest Diagnostics Investments Incorporated Glucagon detection and quantitation by mass spectrometry
HUE055674T2 (hu) 2010-10-29 2021-12-28 Thermo Fisher Scientific Oy Rendszerelrendezés automatizált mintaelõkészítõ és -elemzõ rendszerhez
AU2015261711B2 (en) * 2010-10-29 2017-11-09 Thermo Fisher Scientific Oy Automated system for sample preparation and analysis
EP3920207A1 (en) 2010-12-28 2021-12-08 Quest Diagnostics Investments LLC Quantitation of insulin by mass spectrometry
WO2013177121A2 (en) * 2012-05-21 2013-11-28 Indiana University Research And Technology Corporation Identification and quantification of intact glycopeptides in complex samples
US9169331B2 (en) 2012-12-21 2015-10-27 Dionex Corporation Separation of glycans by mixed-mode liquid chromatography
US9310344B2 (en) 2013-06-14 2016-04-12 Dionex Corporation HILIC/anion-exchange/cation-exchange multimodal media
EP2939024B1 (en) 2012-12-26 2021-04-28 Quest Diagnostics Investments Incorporated C peptide detection by mass spectrometry
US10324082B2 (en) 2015-03-03 2019-06-18 Quest Diagnostics Investments Llc Methods for quantitation of insulin levels by mass spectrometry
CN108226309B (zh) * 2016-12-13 2020-06-16 江苏奥赛康药业有限公司 一种右丙亚胺的分析方法
FI20175244A7 (fi) * 2017-03-17 2018-09-18 Planmeca Oy Itsekalibroiva lääketieteellinen kuvannuslaite
EP4617668A3 (en) 2017-03-31 2025-12-24 Quest Diagnostics Investments LLC Methods for quantitation of insulin and c-peptide
WO2018232338A1 (en) * 2017-06-16 2018-12-20 AesculaTech, Inc. Thermoresponsive polymers and uses thereof
CN110639066B (zh) * 2019-09-27 2020-10-20 北京诺康达医药科技股份有限公司 一种可降解泪管栓及其制备方法与应用
AU2024247888A1 (en) 2023-03-31 2025-10-09 Quest Diagnostics Investments Llc Methods for quantitation of adiponectin by mass spectrometry
KR20250146541A (ko) * 2024-04-01 2025-10-13 주식회사 티엠디랩 형상기억 고분자를 포함하는 누점 플러그 및 이의 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949750A (en) 1974-10-07 1976-04-13 Freeman Jerre M Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
WO1994005342A1 (en) 1992-09-02 1994-03-17 Landec Corporation Occlusion of channels in living mammals
WO2002011783A1 (en) 2000-08-04 2002-02-14 Medennium, Inc. Ocular plug for punctal and intracanalicular implants
WO2006031658A2 (en) * 2004-09-10 2006-03-23 Allergan, Inc. Therapeutic lacrimal canalicular inserts and related methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5575815A (en) * 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
JPH04364839A (ja) * 1991-06-12 1992-12-17 Asahi Chem Ind Co Ltd 涙道閉鎖用ロッド
JP3423317B2 (ja) * 1993-07-19 2003-07-07 アンジオジェネシス テクノロジーズ インコーポレイテッド 抗−血管形成性組成物およびそれにより被覆されたステント
JPH0920651A (ja) * 1995-07-03 1997-01-21 Koken Co Ltd 注入可能な涙小管閉鎖剤
US5962006A (en) * 1997-06-17 1999-10-05 Atrix Laboratories, Inc. Polymer formulation for prevention of surgical adhesions
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US20050092910A1 (en) * 2001-12-08 2005-05-05 Scott Geromanos Method of mass spectrometry
US20040068078A1 (en) * 2001-12-12 2004-04-08 Milbocker Michael T. In situ polymerizing medical compositions
CA2510250A1 (en) * 2002-12-20 2004-08-12 Momenta Pharmaceuticals, Inc. Glycan markers for diagnosing and monitoring disease
WO2005073732A2 (en) * 2004-01-23 2005-08-11 Amgen Inc. Lc/ms method of analyzing high molecular weight proteins
CA2648066C (en) * 2006-03-31 2012-07-03 Forsight Labs, Llc Drug delivery methods, structures, and compositions for nasolacrimal system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949750A (en) 1974-10-07 1976-04-13 Freeman Jerre M Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
WO1994005342A1 (en) 1992-09-02 1994-03-17 Landec Corporation Occlusion of channels in living mammals
WO2002011783A1 (en) 2000-08-04 2002-02-14 Medennium, Inc. Ocular plug for punctal and intracanalicular implants
WO2006031658A2 (en) * 2004-09-10 2006-03-23 Allergan, Inc. Therapeutic lacrimal canalicular inserts and related methods

Also Published As

Publication number Publication date
MX2009004857A (es) 2009-05-21
CN101553207B (zh) 2013-01-16
TWI397426B (zh) 2013-06-01
EP2086502A1 (en) 2009-08-12
ES2415865T3 (es) 2013-07-29
TW200826972A (en) 2008-07-01
CA2669642A1 (en) 2008-05-22
US20080118932A1 (en) 2008-05-22
BRPI0718658A2 (pt) 2013-11-19
ZA200902588B (en) 2010-06-30
AU2007319437A1 (en) 2008-05-22
JP5340161B2 (ja) 2013-11-13
KR20090090320A (ko) 2009-08-25
AR063620A1 (es) 2009-02-04
AU2007319437B2 (en) 2013-01-10
CN101553207A (zh) 2009-10-07
EP2086502B1 (en) 2013-04-17
JP2010508995A (ja) 2010-03-25
WO2008060929A1 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
KR101409436B1 (ko) 수불용성 폴리머 매트릭스를 포함하는 누점마개
US20140128478A1 (en) Punctal plug comprising a water-insoluble polymeric matrix
JP2010508995A5 (enExample)
CN105209016B (zh) 用于细胞递送的生物相容性水凝胶聚合物基体
KR102322747B1 (ko) 프로스타마이드-함유 안구내 이식물
SG187786A1 (en) A biodegradable ocular implant
KR20230107626A (ko) 자궁 내 사용을 위한 인시튜로 형성된 하이드로겔 및 조성물 설계
CN116194091B (zh) 包含水凝胶和环孢菌素的持续释放可生物降解泪小管内插入物
US20250177295A1 (en) Single solution hydrogels with covalent bonding formed in situ, composition design and medical procedures using the hydrogels
AU2005231687B2 (en) New free-radical scavenger containing viscoelastic composition, methods of use and package
CN116133663B (zh) 具有高前列腺酰胺负载量的眼内植入物
JP2004530452A (ja) 外科手術において使用するための非吸引性遷移粘弾性物質
JP7518627B2 (ja) 薬剤徐放性組成物
WO2015133580A1 (ja) 注入可能なポリ乳酸類含有組成物
HK40090731A (zh) 包含水凝胶和环孢菌素的持续释放可生物降解泪小管内插入物
HK40085854A (en) Intraocular implant with high loading of a prostamide
HK1219430B (zh) 用於细胞递送的生物相容性水凝胶聚合物基体

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20170613

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20170613